Sheng-tao Yuan
State Key Laboratory Of Natural Medicines, P.R. China
Nanjing, 210009, China
Nanjing, 210009, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
Recent insights and perspectives into the role of the miRNA‑29 family in innate immunity (Review).
Journal: International journal of molecular medicine
Published: October 07, 2024
C118P exerted potent anti-tumor effects against melanoma with induction of G2/M arrest via inhibiting the expression of BUB1B.
Journal: Journal of dermatological science
Published: June 13, 2022
Metabolism and polarization regulation of macrophages in the tumor microenvironment.
Journal: Cancer letters
Published: March 24, 2022
C118P, a novel microtubule inhibitor with anti-angiogenic and vascular disrupting activities, exerts anti-tumor effects against hepatocellular carcinoma.
Journal: Biochemical pharmacology
Published: March 13, 2021
Targeting GLS1 to cancer therapy through glutamine metabolism.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: January 23, 2021
The comprehensive landscape of miR-34a in cancer research.
Journal: Cancer metastasis reviews
Published: December 17, 2020
Alterations of housekeeping proteins in human aged and diseased hearts.
Journal: Pflugers Archiv : European journal of physiology
Published: November 14, 2020
I-8, a novel inhibitor of mutant IDH1, inhibits cancer progression in vitro and in vivo.
Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Published: May 15, 2019
Synergistic combination of DT-13 and Topotecan inhibits aerobic glycolysis in human gastric carcinoma BGC-823 cells via NM IIA/EGFR/HK II axis.
Journal: Journal of cellular and molecular medicine
Published: March 26, 2019
Design, Synthesis, and Biological Evaluation of Novel Biotinylated Podophyllotoxin Derivatives as Potential Antitumor Agents.
Journal: Frontiers in chemistry
Published: March 13, 2019
Last Updated: 09/26/2026